drugset / Trial / NCT06510816
A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of the study is to determine if IVT injections of vonaprument every month reduce vision loss in participants with dry AMD with GA.
Timeline
- Start
- 2024-07-30
- Primary completion
- 2026-10-31
- Completion
- 2027-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ANX007 | Unknown | — | Intravitreal |